APP and neoplasm: PTX moiety in APP molecule may contribute to this differential effect, since there are few studies demonstrating that PTX may inhibit pro-inflammatory cytokine (IL-12 and IFN-γ) secretion or deplete DC in tumor tissues (55, 56).